posted on 2016-07-01, 19:02authored byBora Shin, Byung-Yong Kim, Eunji Cho, Ki-Bong Oh, Jongheon Shin, Michael Goodfellow, Dong-Chan Oh
A new secondary metabolite, actinomadurol
(1), was
isolated along with the known compound JBIR-65 (2) from
a rare actinomycete, Actinomadura strain KC 191.
The structure of 1 was established as a rare member of
the bacterial C-19 norditerpenoid
class by NMR data and ECD calculations. The absolute configuration
of 2, which was previously reported without stereochemical
analysis, was determined by using the modified Mosher’s method
and ECD calculations. Actinomadurol (1) exhibited potent
antibacterial activity against pathogenic strains, such as Staphylococcus aureus, Kocuria rhizophila, and Proteus hauseri (MIC = 0.39–0.78 μg/mL),
whereas JBIR-65 (2) showed no antibacterial activity.